Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-21-016323
Filing Date
2021-07-07
Accepted
2021-07-07 12:55:39
Documents
1
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3467
  Complete submission text file 0001493152-21-016323.txt   4910
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Issuer) CIK: 0001569340 (see all company filings)

EIN.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELL SOURCE, INC. 65 YIGAL ALON STREET TEL AVIV L3 67433
Business Address
ZOLTY DAVID (Reporting) CIK: 0001638322 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55413 | Film No.: 211076953